Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Immunohistochemistry of cyclin D3 in pulmonary carcinomas


Cyclin D3, a cell cycle regulator, is encoded in the 6q21 chromosome region. Abnormalities of this gene and its protein product have not been found in normal tissues or in malignancies from human subjects. The expression of cyclin D3 was studied immunohistochemically in archival formalin-fixed, paraffin-embedded specimens from normal organs obtained from three autopsy cases and 237 human primary pulmonary carcinomas. In normal organs, nuclear positivity for cyclin D3 was observed in reactive type-2 pneumocytes, islets of Langerhans, lymphocytes from lymph nodes, superficial cells of transitional epithelium, epithelium of oesophagus, stomach, small intestine and gallbladder, endothelium, smooth muscles, and brain. Proliferating cells such as lymphocytes in the germinal centres and non-proliferating cells such as neurons both demonstrated cyclin D3 immunoreactivity. Cyclin D3 showed obvious nuclear immunoreactivity in 168 pulmonary carcinomas (71%). The proportion of tumour cells that were cyclin D3-positive ranged from 1% to 73% (median, 16%). There was no relationship between cyclin D3 immunoreactivity and histological typing, tumour differentiation, or pathological TNM staging. In pulmonary carcinomas, distinct expression of the cyclin D3 protein is unlikely to be implicated in tumorigenesis, because of its expression in only a small fraction of cancer cells. It may relate to cancer progression. The distribution of cyclin D3 reactivity in the normal tissues suggests that cyclin D3 affects other processes than cell cycle regulation in a lineage-specific manner.

This is a preview of subscription content, log in to check access.


  1. 1.

    Adèlaide J, Monges G, Dèrdèrian C, Seitz J-F, Birnbaum D (1995) Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1. Br J Cancer 71:64–68

  2. 2.

    Ando K, Ajchenbaum-Cymbalista F, Griffin JD (1993) Regulation of G1/S transition by cyclin D2 and D3 in hematopoietic cells. Proc Natl Acad Sci USA 90:9571–9575

  3. 3.

    Bartkova J, Lukas J, Müller H, Lützhøft D, Strauss M, Bartek J (1994) Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 57:353–361

  4. 4.

    Bartkova J, Lukas J, Müller H, Strauss M, Bartek J (1994) The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int J Cancer 58:568–573

  5. 5.

    Bartkova J, Lukas J, Strauss M, Bartek J (1994) Cell cycle-related variation and tissue-restricted expression of cyclin D1 protein. J Pathol (Lond) 172:237–245

  6. 6.

    Bartkova J, Lukas J, Strauss M, Bartek J (1995) Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 10:775–778

  7. 7.

    Bartkova J, Lukas J, Müller H, Strauss M, Gusterson B, Bartek J (1995) Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 55:949–956

  8. 8.

    Berenson JR, Yang J, Mickel RA (1989) Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Oncogene 4:1111–1116

  9. 9.

    Buckley MF, Sweeney KJE, Hamilton JA, Sini RL, Manning DL, Nicholson RI, Fazio A de, Watts CKW, Musgrove EA, Sutherland RL (1993) Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127–2133

  10. 10.

    Cattoretti G, Becker MH, Key G, Duchrow M, Schlüter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol (Lond) 168:357–363

  11. 11.

    Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J-Y, Livingston DM (1993) Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487–497

  12. 12.

    Faust JB, Meeker TC (1992) Amplification and expression of the bcl-1 gene in human solid tumor cell lines. Cancer Res 52:2460–2463

  13. 13.

    Gillett C, Fantl V, Smith R, Fishewr C, Bartek J, Dickson C, Barnes D, Peters G (1994) Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54:1812–1817

  14. 14.

    Hermanek P, Sobin LH (1987) TNM classification of malignant tumors. Union Internationale Contre le Cancer, Geneva, pp 69–73

  15. 15.

    Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA (1992) Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993–1006

  16. 16.

    Hunter T, Pines J (1991) Cyclins and cancer. Cell 66:1071–1074

  17. 17.

    Inaba T, Matsushime H, Valentine M, Roussel MF, Sherr CJ, Look AT (1992) Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. Genomics 13:565–574

  18. 18.

    Jiang W, Kahn SM, Tomita N, Zhang Y-J, Lu S-H, Weinstein B (1992) Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 52:2980–2983

  19. 19.

    Jiang W, Zhang Y-J, Kahn SM, Hollstein MC, Santella RM, Lu S-H, Harris CC, Montesano R, Weinstein IB (1993) Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 90:9026–9030

  20. 20.

    Kato J-Y, Sherr CJ (1993) Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1. Proc Natl Acad Sci USA 90:11513–11517

  21. 21.

    Kato J-Y, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ (1993) Direct binding of cyclin D to the retinoblastoma protein product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7:331–342

  22. 22.

    Lammie GA, Fantl V, Smith R, Schuuring E, Brookes S, Michalides R, Dickson C, Arnold A, Peters G (1991) D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6:439–444

  23. 23.

    Leach FS, Elledge SJ, Sherr CJ, Willson JKV, Markowitz S, Kinzler KW, Vogelstein B (1993) Amplification of cyclin genes in colorectal carcinomas. Cancer Res 53:1986–1989

  24. 24.

    Matsushime H, Roussel MF, Ashmun RA, Sherr CJ (1991) Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65:701–713

  25. 25.

    Motokura T, Arnold A (1993) Cyclins and oncogenesis. Biochim Biophys Acta 1155:63–78

  26. 26.

    Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A (1991) A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350:512–515

  27. 27.

    Motokura T, Keyomarsi K, Kronenberg HM, Arnold A (1992) Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene. J Biol Chem 267:20412–20415

  28. 28.

    Palmero I, Holder A, Sinclair A, Dickson C, Peters G (1993) Cyclins D1 and D2 are differentially expressed in human Blymphoid cell lines. Oncogene 8:1049–1054

  29. 29.

    Schuuring E, Verhoeven E, Mooi WJ, Michalides RJAM (1992) Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7:355–361

  30. 30.

    Seto M, Yamamoto K, Iida S, Akao Y, Utsumi KR, Kubonishi I, Miyoshi I, Ohtsuki T, Yawata Y, Namba M, Motokura T, Arnold A, Takahashi T, Ueba R (1992) Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene 7:1401–1406

  31. 31.

    Shapiro GI, Edwards CD, Kobzik L, Godleski J, Richards W, Sugarbaker DJ, Rollins B (1995) Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res 55:505–509

  32. 32.

    Sherr CJ (1993) Mammalian G1 cyclins. Cell 73:1059–1065

  33. 33.

    Theillet C, Adnane J, Szepetowski P, Simon M-P, Jeanteur P, Birnbaum D, Gaudray P (1990) BCL-1 participates in the 11q13 amplification found in breast cancer. Oncogene 5:147–149

  34. 34.

    Tsuruta H, Sakamoto H, Onoda M, Terada M (1993) Amplification and overexpression of EXP1 and EXP2/cyclin D1 genes in human esophageal carcinomas. Biochem Biophys Res Commun 196:1529–1536

  35. 35.

    Withers DA, Harvey RC, Faust JB, Melnyk O, Carey K, Meeker TC (1991) Characterization of a candidate bcl-1 gene. Mol Cell Biol 11:4848–4853

  36. 36.

    World Health Organization (1981) Histological typing of lung tumours, 2nd edn. World Health Organization, Geneva

  37. 37.

    Xiong Y, Menninger J, Beach D, Ward DC (1992) Molecular cloning a chromosomal mapping of CCND genes encoding human D-type cyclins. Genomics 13:575–584

  38. 38.

    Zhang S-Y, Caamano J, Cooper F, Guo X, Klein-Szanto AJP (1994) Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol 102:695–698

  39. 39.

    Zhang YJ, Jiang W, Chen CJ, Lee CS, Kahn SM, Santella RM, Weinstein IB (1993) Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 196:1010–1016

Download references

Author information

Correspondence to H. Usuda.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Usuda, H., Naito, M., Saito, T. et al. Immunohistochemistry of cyclin D3 in pulmonary carcinomas. Vichows Archiv A Pathol Anat 428, 159–163 (1996).

Download citation

Key words

  • Cyclin D3
  • Immunohistochemistry
  • Pulmonary carcinoma